ImmunoGen
IMGN
#1870
Rank
$8.72 B
Marketcap
$31.23
Share price
0.00%
Change (1 day)
134.11%
Change (1 year)

Revenue for ImmunoGen (IMGN)

Revenue in 2023 (TTM): $0.28 Billion USD

According to ImmunoGen 's latest financial reports the company's current revenue (TTM ) is $0.28 Billion USD. In 2022 the company made a revenue of $0.10 Billion USD an increase over the revenue in the year 2021 that were of $69.85 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunoGen from 1996 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) $0.28 B164.39%
2022 $0.10 B55.72%
2021 $69.85 M-47.2%
2020 $0.13 B60.81%
2019 $82.27 M53.93%
2018 $53.44 M-53.71%
2017 $0.11 B
2015 $56.91 M-23.21%
2014 $74.12 M-2.61%
2013 $76.11 M489.68%
2012 $12.9 M-40.98%
2011 $21.86 M42.7%
2010 $15.32 M-18.2%
2009 $18.73 M-45.75%
2008 $34.53 M-12.68%
2007 $39.54 M5.27%
2006 $37.56 M17.28%
2005 $32.02 M-8.37%
2004 $34.95 M194.75%
2003 $11.85 M53.32%
2002 $7.73 M44.88%
2001 $5.33 M-29.78%
2000 $7.6 M-23.2%
1999 $9.9 M890%
1998 $1 M150%
1997 $0.4 M0%
1996 $0.4 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$2.30 B 699.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.53 B 11,211.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.86 B 14,107.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$47.43 B 16,392.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$87.69 B 30,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$55.64 B 19,246.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$49.94 B 17,263.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$53.50 B 18,503.80%๐Ÿ‡ซ๐Ÿ‡ท France